Walgreens Boots Alliance, Inc. (WBA) Set to Announce Earnings on Wednesday
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) will be posting its quarterly earnings results on Wednesday, October 18th. Analysts expect Walgreens Boots Alliance to post earnings of $1.21 per share for the quarter.
Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 69.85 on Wednesday. The company’s 50-day moving average is $79.43 and its 200-day moving average is $80.94. Walgreens Boots Alliance, Inc. has a one year low of $69.28 and a one year high of $89.69. The company has a market cap of $74.75 billion, a price-to-earnings ratio of 17.64 and a beta of 1.25.
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were given a $0.40 dividend. The ex-dividend date was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 2.29%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is presently 40.30%.
Walgreens Boots Alliance announced that its Board of Directors has initiated a stock buyback program on Thursday, June 29th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s board believes its shares are undervalued.
WARNING: “Walgreens Boots Alliance, Inc. (WBA) Set to Announce Earnings on Wednesday” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/10/11/walgreens-boots-alliance-inc-wba-set-to-announce-earnings-on-wednesday.html.
Several brokerages have recently issued reports on WBA. Royal Bank Of Canada began coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price target on the stock. Needham & Company LLC reissued a “buy” rating and set a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Saturday, September 16th. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, September 12th. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Finally, UBS AG reissued a “buy” rating and set a $96.00 price target (down previously from $97.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, August 23rd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $91.31.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.